What is Dianthus Therapeutics's return on invested capital?

Dianthus Therapeutics (DNTH) reported return on invested capital of -35.2% in Q3 2025.

How has Dianthus Therapeutics's return on invested capital changed year-over-year?

Dianthus Therapeutics's return on invested capital increased by 30.6% year-over-year, from -50.8% to -35.2%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.

Dianthus Therapeutics DNTH Return on invested capital

Return on invested capital at other companies

Johnson & JohnsonJNJ

20.6%+0.3pp

AmgenAMGN

14.1%+4.0pp

AnaptysBio, Inc.ANAB

-255.3%-510pp

Vor BiopharmaVOR

-153.1%-5,641pp

Protagonist TherapeuticsPTGX

-27.6%-33.2pp

Cullinan Therapeutics, Inc.CGEM

-58%+22.6pp

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$5.01B+823%

Enterprise value$4.38B+721%

P/S1,626.3×+1,068×

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Calculated from Dianthus Therapeutics’s reported figures.

nopat/invested capital=-35.2%

Based on trailing twelve months.

The official record: Dianthus Therapeutics’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's return on invested capital?: Dianthus Therapeutics (DNTH) reported return on invested capital of -35.2% in Q3 2025.
How has Dianthus Therapeutics's return on invested capital changed year-over-year?: Dianthus Therapeutics's return on invested capital increased by 30.6% year-over-year, from -50.8% to -35.2%.
What does return on invested capital mean?: Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.